
Brokerage BMO Capital Markets raises price target on U.S.-listed shares of Canadian agrichemical company Nutrien NTR.TO, NTR.N to $85 from $75
The new PT represents upside of 18.4% to stock's last close
Brokerage expects potash markets to stay stable while noting emerging generic crop‑protection pressures in some direct‑to‑grower competitive models
Says co continues to evaluate strategic options for Brazilian Retail, with potential direction expected later in 2026
"Nutrien continues discussions with the government in Trinidad regarding gas and port fees; while no workforce reductions have occurred to date, this could change absent progress," - BMO
Brokerage Raymond James also raises PT to $74 from $68, an upside of 3.1% to stock's last close
12 of 23 brokerages rate the stock "buy" or higher, 9 "hold" and 2 "sell", median PT is $70.50 - LSEG data
In 2025, NTR was up 29.7%